India to South Africa: Escitalopram Export Trade Route

The India to South Africa Escitalopram corridor is one of India's established pharmaceutical export routes, with 92 shipments documented worth a combined $4.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's escitalopram manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $44.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with escitalopram's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #5 among India's top escitalopram export destinations globally.

On the import side, key buyers of Indian escitalopram in South Africa include ACCORD HEALTHCARE C/O UPD LEA GLEN, MEDPRO PHARMACEUTICA PTY LIMITED, AUROGEN SOUTH AFRICA (PTY) LTD, and 18 others. ACCORD HEALTHCARE C/O UPD LEA GLEN is the single largest importer with 22 shipments valued at $2.6M USD.

India's escitalopram exports to South Africa are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, CIPLA LIMITED, AUROBINDO PHARMA LTD — together account for 86% of total trade value on this route. The average shipment value of $44.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru.& med.: accord escitalopram tablets 10mg (each tablet contains: escitalopram 10mg) [2x14t per pack] and lexamil 5mg tab escitalopram oxalate 5m, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE C/O UPD LEA GLEN is the largest importer with 22 shipments worth $2.6M USD — representing 63% of all escitalopram imports from India on this route. A total of 21 buyers are active on this corridor.